A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia
NCT07686679 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2026-08-10
Summary
This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia
Conditions
- Functional Dyspepsia
Interventions
- DRUG
-
DA-9701
1 tablet, TID
- DRUG
-
DA-9701-R
1 tablet, TID
- DRUG
-
DA-9701 Placebo
1 tablet, TID
- DRUG
-
DA-9701-R Placebo
1 tablet, TID
Sponsors & Collaborators
-
Dong-A ST Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-06
- Primary Completion
- 2027-10-31
- Completion
- 2027-10-31
Countries
- South Korea
Study Locations
More Related Trials
-
Phase I Clinical Trial of DA-6886 in Healthy Male Subjects
NCT01633723 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Demonstrate the Efficacy and Safety of Motilitone®
NCT01817465 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
NCT02567578 ·Status: TERMINATED ·Phase: PHASE2
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients
NCT03971383 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia
NCT01355276 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
NCT06755671 ·Status: RECRUITING
-
Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea
NCT05719896 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Trial of Motilitone on Gastric Motor Function in Healthy Volunteers
NCT01719575 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Investigation of Motilium's Effectiveness and Safety for the OTC Treatment of Dyspepsia-related Symptoms
NCT07028671 ·Status: COMPLETED
-
Zhizhu Kuanzhong Capsule for Patients With Functional Dyspepsia-Postprandial Distress Syndrome
NCT04380233 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS
NCT06139744 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy of Banhasasim-tang on Functional Dyspepsia
NCT00987805 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method
NCT02151708 ·Status: UNKNOWN ·Phase: NA
-
Open-Label Placebo for Functional Dyspepsia
NCT03745781 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup
NCT04647955 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method
NCT02091635 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation
NCT02082457 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
NCT05923892 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Bioactive Peptides' Effect on Digestive Discomfort Symptoms of the Elderly
NCT04450979 ·Status: COMPLETED ·Phase: NA
-
PEA in Functional Dyspepsia
NCT05877781 ·Status: RECRUITING ·Phase: NA
-
The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects
NCT04008901 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
NCT00584298 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
NCT07016269 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
NCT05655819 ·Status: COMPLETED ·Phase: PHASE1/PHASE2